Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pneumococcal glycoconjugate vaccines produce antibody responses that strongly correlate with function.

× No keyword cloud information.

12 in total

1. Opsonophagocytic activity following a reduced dose 7-valent pneumococcal conjugate vaccine infant primary series and 23-valent pneumococcal polysaccharide vaccine at 12 months of age.

Authors: F M Russell; J R Carapetis; R L Burton; J Lin; P V Licciardi; A Balloch; L Tikoduadua; L Waqatakirewa; Y B Cheung; M L K Tang; M H Nahm; E K Mulholland
Journal: Vaccine Date: 2010-10-31 Impact factor: 3.641

Review 2. Carbohydrate vaccines: developing sweet solutions to sticky situations?

Authors: Rena D Astronomo; Dennis R Burton
Journal: Nat Rev Drug Discov Date: 2010-04 Impact factor: 84.694

3. Infants aged 12 months can mount adequate serotype-specific IgG responses to pneumococcal polysaccharide vaccine.

Authors: Anne Balloch; Paul V Licciardi; Fiona M Russell; Edward K Mulholland; Mimi L K Tang
Journal: J Allergy Clin Immunol Date: 2010-06-26 Impact factor: 10.793

4. Safety and immunogenicity of the 23-valent pneumococcal polysaccharide vaccine at 12 months of age, following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine in infancy.

Authors: F M Russell; P V Licciardi; A Balloch; V Biaukula; L Tikoduadua; J R Carapetis; J Nelson; A W J Jenney; L Waqatakirewa; S Colquhoun; Y B Cheung; M L K Tang; E K Mulholland
Journal: Vaccine Date: 2010-03-01 Impact factor: 3.641

Review 5. Combined schedules of pneumococcal conjugate and polysaccharide vaccines: is hyporesponsiveness an issue?

Authors: Katherine L O'Brien; Michael Hochman; David Goldblatt
Journal: Lancet Infect Dis Date: 2007-09 Impact factor: 25.071

6. Immune response in infants to the heptavalent pneumococcal conjugate vaccine against vaccine-related serotypes 6A and 19A.

Authors: Hyunju Lee; Moon H Nahm; Robert Burton; Kyung-Hyo Kim
Journal: Clin Vaccine Immunol Date: 2009-01-14

7. Immunogenicity following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine.

Authors: F M Russell; A Balloch; M L K Tang; J R Carapetis; P Licciardi; J Nelson; A W J Jenney; L Tikoduadua; L Waqatakirewa; J Pryor; G B Byrnes; Y B Cheung; E K Mulholland
Journal: Vaccine Date: 2009-07-17 Impact factor: 3.641

8. Pneumococcal vaccination in older adults induces antibodies with low opsonic capacity and reduced antibody potency.

Authors: Jeremy G Schenkein; Saeyoung Park; Moon H Nahm
Journal: Vaccine Date: 2008-08-13 Impact factor: 3.641

Review 9. Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and X-ray defined pneumonia in children less than two years of age.

Authors: Marilla G Lucero; Vernoni E Dulalia; Leilani T Nillos; Gail Williams; Rhea Angela N Parreño; Hanna Nohynek; Ian D Riley; Helena Makela
Journal: Cochrane Database Syst Rev Date: 2009-10-07

10. Essential criteria for evaluation of pneumococcal conjugate vaccine candidates.

Authors: Peter Paradiso
Journal: Vaccine Date: 2009-08-21 Impact factor: 3.641

1 in total

1. Pneumococcal polysaccharide vaccine at 12 months of age produces functional immune responses.

Authors: Paul V Licciardi; Anne Balloch; Fiona M Russell; Robert L Burton; Jisheng Lin; Moon H Nahm; Edward K Mulholland; Mimi L K Tang
Journal: J Allergy Clin Immunol Date: 2012-02-02 Impact factor: 10.793

1 in total